Gastrinomas: a historical perspective.
The journey of gastrinomas had its beginnings in 1955 when Zollinger and Ellison published their seminal paper (Zollinger and Ellison, Ann Surg 1955; 142: 709-723). The evolution of the diagnosis and management of this syndrome has paralleled many important advances in medicine, including the development of various diagnostic tools to the major impact of medical treatment on the management of an inherently surgical pathology. There are numerous excellent review articles on the most current developments and treatment options of gastrinomas available in the literature today. The purpose of this paper is to present a historical perspective on this most fascinating condition. This article will illustrate the way in which the discovery of gastrinomas evolved and how its management has developed with it. The evolution of the surgical treatment of gastrinomas has evolved over the last 50 years.
Yeung
Meei J
MJ
Department of Surgery, Monash University Endocrine Surgery Unit, Alfred Hospital, Melbourne, Australia.
Pasieka
Janice L
JL
D000970:Antineoplastic Agents / Q000627:therapeutic use; D004067:Digestive System Neoplasms / Q000235:genetics / Q000266:history* / Q000628:therapy; D013505:Digestive System Surgical Procedures; D015408:Gastrinoma / Q000235:genetics / Q000266:history* / Q000628:therapy; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D011518:Proto-Oncogene Proteins; D015043:Zollinger-Ellison Syndrome / Q000175:diagnosis / Q000235:genetics / Q000266:history*
D000970:Antineoplastic Agents; C105373:MEN1 protein, human; D011518:Proto-Oncogene Proteins